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We present a case of trichoblastic carcinosarcoma with panfollicular differentiation.
An 80-year-old man presented with a lesion on the left ear, which had been present
for several months. Histopathology revealed a well-demarcated neoplasm in the der-
mis composed of intimately intermingled malignant epithelial and mesenchymal cells.
The epithelial component showed multilineage follicular differentiation toward all of
the elements of a normal hair follicle. Molecular analysis revealed identical molecular
aberrations in both epithelial and mesenchymal components including CTNNB1 and
SUFU mutations. To the best of our knowledge, this is the first report of panfollicular
carcinosarcoma and of the presence of a CTNNB1 mutation in trichoblastic
carcinosarcoma.
1 | INTRODUCTION
Trichoblastic carcinosarcoma is an exceedingly rare biphasic cutane-
ous malignant neoplasm featuring a mixture of epithelial elements,
resembling follicular germinative cells, along with mesenchymal com-
ponent. Only eight cases of trichoblastic carcinosarcoma have been
reported in the literature.1 A few cases of trichoblastic carcinosar-
coma showed differentiation toward various elements of the hair fol-
licle, for example, clear-cell change in epithelial aggregates and
trichohyalin keratinization.2,3 In contrast to trichoblastic carcinoma,
multiple paths of hair follicle differentiation or panfollicular differen-
tiation have not been reported in trichoblastic carcinosarcoma.4 In
this report, we present a unique case of trichoblastic carcinosarcoma
with panfollicular differentiation (or panfollicular carcinosarcoma). In
addition, we investigate the molecular changes underlying this
neoplasm.
2 | CASE REPORT
An 80-year-old man with no relevant past medical history presented
with a lesion on the left ear, which had been present for a few
months. Histopathology revealed a well-demarcated neoplasm in the
dermis without subcutaneous involvement or connection to the epi-
dermis (Figure 1). The lesion was composed of intimately intermingled
malignant epithelial and mesenchymal cells. The vast majority of the
tumor consisted of an epithelial follicular germinative cell component
arranged in nodular, retiform, and petaloid patterns composed of
atypical basaloid cells. The cells were relatively small with high
nuclear-cytoplasmic ratio, and had oval vesicular pleomorphic nuclei,
sometimes with a prominent nucleolus. Mitotic figures were conspicu-
ous. Throughout the lesion, the epithelial component showed
multilineage follicular differentiation toward all of the elements of a
normal hair follicle (Figure 2). Upper and lower hair segment differen-
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tiation was represented by the formation of keratocysts and
infundibulocystic structures (infundibular/upper isthmic differentia-
tion), ghost/matrical cells and bright red trichohyalin granules (inner
root sheath differentiation of the bulb and stem), and focal presence
of eosinophilic cells with central apoptosis (trichilemmal differentia-
tion of the outer root sheath). In addition, intracellular hyaline glob-
ules, foci of calcification, and epithelial structures resembling hair
papillae were seen and signet ring cell differentiation was present
(myoepithelial differentiation). The mesenchymal component was inti-
mately intermingled with the epithelial component and showed an
organoid growth pattern with papillary mesenchymal bodies. On the
one hand, the spindle cells showed indistinct cytoplasmic borders,
round-oval to elongated nuclei and small nucleoli. However, dispersed
throughout the spindle cells, multinucleated pleomorphic cells with
prominent nucleoli were also present.
Immunohistochemically, the epithelial component was positive
for cytokeratin (CKAE1/AE3), BerEp4 (partially), and p63. Aberrant
expression of p53 was demonstrated in both components. Interest-
ingly, both the epithelial and mesenchymal components revealed focal
strong nuclear beta-catenin staining, mainly in inner root cells, matrical
cells, and spindle cells. Ki-67 proliferation index was high (30%) in
both components and accentuated the nuclear polymorphism in both
components (Figure 3).
Molecular analysis using targeted next-generation sequencing
(NGS) of cancer-associated genes and single-nucleotide polymorphism
(SNP) analysis for copy number alterations was performed using two
different gene panels (Supporting Information). Separate areas of epi-
thelial and mesenchymal components were microdissected under a
stereomicroscope (ZEISS SteREO Discovery.V8). There was no over-
lap between the two components. Analysis revealed identical muta-
tions in both elements, that is, TERT promoter and TP53 mutation, an
activating mutation in CTNNB1 (encoding beta-catenin) and truncating
mutations in both CDKN2A (encoding p16/p14arf) and SUFU (a nega-
tive regulator of Hedgehog signaling) (Table 1). Mutations in CTNNB1
F IGURE 1 Scanning
magnification demonstrates a
biphasic cutaneous tumor (A,
H&E magnification 61×), the







of atypical cells with polymorphic
and pleomorphic nuclei (D, H&E
magnification 200×), also note
the multinucleated pleomorphic
cells with prominent nucleoli
dispersed between the spindle
cells (E; H&E magnification 200×)
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and SUFU were present in both components with a lower variant allele
frequency than expected based on the tumor cell percentage, indica-
tive for subclonal presence of both mutations. Additionally, identical
copy number alterations including imbalance of chromosomes 3p, 4q,
and 19 and loss of 5q, 9p, 10, 13q, and 17 were identified in both
components. Mutations in PTCH1 and SMO, the key components of
the Hedgehog pathway, commonly involved in basal cell carcinoma
carcinogenesis, were not found in this tumor.
3 | DISCUSSION
Trichoblastic carcinosarcoma is an exceedingly rare tumor. To date,
only eight cases have been reported in the literature.1 Our report is
the first case to describe panfollicular differentiation within
trichoblastic carcinosarcoma. Due to the rarity and underreporting of
trichoblastic carcinosarcoma, knowledge of the exact etiology is lim-
ited. Several hypotheses have been proposed to explain biphasic
tumors: two distinct tumors connecting (collision tumor), divergent
differentiation originating from a single progenitor cell toward epithe-
lial and mesenchymal cells (monoclonal), and multiclonal origin.5 Our
data strongly support the monoclonal origin of both components, in
line with a previous study that showed similar genetic and chromo-
somal aberrations in epithelial and mesenchymal components in cuta-
neous carcinosarcoma.6
Interestingly, using immunohistochemistry, we found nuclear
beta-catenin staining in parts of both the epithelial and mesenchymal
components. Indeed, additional molecular analysis confirmed a
CTNNB1 mutation (exon 3: c.134_135delinsTG; p.S45L). This specific
mutation in Serine 45 has not been reported earlier, although Serine
F IGURE 2 Figure 2 A-D, Histopathological features of the various differentiation: inner root sheath differentiation of the bulb and stem with
ghost/matrical cells (A, H&E magnification 100×), and bright red trichohyalin granules; (B, H&E magnification 200×). Infundibular differentiation
with infundibulocystic and squamous structures surrounded by mesenchymal cells (C, H&E magnification 120×). Cells with signet ring cell
appearance (myoepithelial differentiation) (D, H&E magnification 200×). Eosinophilic cells with central apoptosis (trichilemmal differentiation of
outer root sheath) (E, H&E magnification 100×)
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F IGURE 3 Figure 3 A-G, Area with epithelial and
mesenchymal component (A, H&E magnification 100×),
strong nuclear beta-catenin expression was noted in
both epithelial and mesenchymal cells (B, magnification
100×), cytokeratin AE1/AE3 showed strong expression
in epithelial cells and negative staining in mesenchymal
cells. (C, magnification 50×), p63 were strongly
expressed in malignant epithelial cells, while negative in
mesenchymal cells (D, magnification 50×), BerEP4
showed focally weak expression in the malignant
epithelial cells (E, magnification 50×), Ki-67 proliferation
was high in both components (F, magnification 50×),
aberrant expression of p53 was demonstrated in both
components (G, magnification 50×)
TABLE 1 Mutations and corresponding variant allele frequencies (VAF) in both tumor components
Epithelial component Mesenchymal component
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45 is a mutational hotspot in other tumor types and different muta-
tions in this residue have been shown to be oncogenic/activating.
Mutations in exon 3 are associated with translocation of the beta-
catenin protein from the membrane to the nucleus and activation of
Wnt/beta-catenin signaling. Aberrant expression of beta-catenin has
been reported in tumors with matrical differentiation, such as
pilomatricoma, pilomatrix carcinoma, and basal cell carcinoma with
matrical differentiation. Furthermore, Kazakov et al described one
case of a trichoblastoma harboring a CTNNB1 mutation. To our knowl-
edge, this is the first report of a trichoblastic carcinosarcoma harbor-
ing a CTNNB1 mutation.7 Wnt/beta-catenin signaling seems to play a
role in multiple processes. Firstly, it has been shown to be involved in
hair follicle development and differentiation.8,9 Secondly, beta-catenin
may regulate stem cell pluripotency since Wnt activation leads to
binding of beta-catenin to transcription factors resulting in pluripotent
gene regulation.10 Gat et al demonstrated that stabilized beta-catenin
in mice undergoes a process leading to de novo hair follicle morpho-
genesis, and they suggest that aberrant beta-catenin activation results
in follicular tumors.11 In the case of trichoblastic carcinosarcoma, it is
likely that dysregulation of Wnt signaling leads to dysregulated follicu-
lar differentiation.
The Hedgehog signaling pathway is essential for embryonic
development and plays a crucial role in tumorigenesis. The SUFU pro-
tein acts as a negative regulator of the Hedgehog signaling pathway
by binding to and inhibiting Gli1 protein. Inactivating mutations in
SUFU can result in upregulation of Gli transcription factors leading to
aberrant activation of the Hedgehog pathway. Furthermore, Hedge-
hog signaling regulates the growth and morphogenesis of hair follicle
epithelium during the anagen portion of the hair cycle.12 Our case
showed SUFU mutation in both components of the tumor. Mutations
in SUFU gene have been associated with Gorlin syndrome, multiple
hereditary infundibulocystic basal cell carcinoma syndrome, familial
meningioma, and medulloblastoma.13 However, it should be noted
that, unlike in our case, the abovementioned were germline SUFU
mutations.
According to the literature, trichoblastic carcinosarcoma are more
frequently seen in older individuals, with male predominance, and are
mainly located in the head and neck region, as in our case. Tri-
choblastic carcinosarcoma has not been reported in young adults or
children.1,2
No guidelines regarding treatment and follow-up of trichoblastic
carcinosarcoma have been established because of the rarity of these
tumors. In our patient, re-excision with Mohs surgery was performed
since the tumor was found close to the resection margin in the first
excision. Although the follow-up period is limited, there has been no
local recurrence over a period of 6 months. There were no lymph
node metastases.
In conclusion, we describe the first case of trichoblastic carcino-
sarcoma with panfollicular differentiation and identify identical molec-
ular changes, including beta-catenin and SUFU mutations, in the
epithelial and mesenchymal components, suggesting that trichoblastic
carcinosarcoma might originate from a single progenitor cell
(monoclonal hypothesis). This finding may shed light on the underlying
biology of this tumor type. However, further investigation including
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